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Wyniki: U 92 pacjentów stwierdzono 99
spływów, identyfikacja WW w 94,9 % spływów,
w 17 przypadkach (18,5 %) stwierdzono
przerzut w WW i wykonano Iimfadenektomię
przy czym w 13 przypadkach (76,5 %) WW był
j~dynym zwierającym meta. Wyniki fałszywie
uJemne- 1 przypadek (1,01 %).
Wnioski:
1. Biopsja WW jest metodą wiarygodną
w ocenie stanu regionalnych węzłów chłonnych
wCS.
2. Aż w 76,5 % przypadków stwierdzano
przerzuty tylko w węźle wartowniczym
co świadczy o wartości biologicznej tego
badania w ocenie stopnia zaawansowania.
91.
EARLY TOXICITY IN 3 D CRT Of
LUNG CANCER
M. Matecka-Nowak, o. Fundowicz,
E. Adamiak, P. Milecki, G. Stryczyńska
Greatpoland Cancer Centre, Poznań
Aim: Evaluation the influence of irradiated
volume of lung on pneumonitis in 3D
radiotherapy.
Material/methods and Results: We
evaluated 49 patients with diagnosis of non-
smali-celi lung cancer (NSCLC) who were
treated in our department between 1999 and
2000. The mean age of patinets was 62 years.
The Karnofsky index was documented in all
patients before, during and after completion of
irradiation. Ali patients represented lilA clinical
stage of lung cancer. Fourteen patients were
irradiated postoperatively due to the residual
tumour or massive nodal involvmenł. Thirty five
patients were treated with exclusive
radiotherapy. No patients have been treated by
chemotherapy. We performed 3D CRT with total
dose in range 60 to 66Gy in daily tractions of 2
Gy prescribed to isocentric poinł. Clinical and
radiological evaluation of pneumonitis was
performed. 21 patients of 49 had radiation
pneumonitis, but intensity of pneumonitis was
moderate. For beUer estimation the toxicity the
dose volume histograms (DVH) were used. The
volume ot irradiated lung was an important
factor for pneumonitis progress.
Conclusions: Dose volume histograms (DVH)
with clinical evaluation can predict pulmonary
toxicity (pneumonitis) and colud allow us to
evaluate volume of irradiated lung with the
highest acceptable dose.
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MEOULLOBLASTOMA IN MATERIAL
Of GREATPOLANO CANCER CEN-
TER BETWEEN 1990 AND 1997
G. Mróz-Bąk, O. Jezierska, E. Nowakowska,
M. Kubaszewska
Greatpoland Cancer Center, Poznań
Introduction: Medulloblastoma represents
4% of all primary brain tumours.
Material and method: Between 1990-97
7 adults with medulloblastoma were irradiated (4
males, 3 females). It represented 1.7% of all
primary brain tumours (we had 400 cases ot
them during this time). Patients were aged
between 18-35 years (median 27.4 years).
5 patients had radical surgical tumour removal.
4 patients had tumour in cerebellar hemispheres
and 3 in cerebellar vermis. 1 patient was
irradiated with Co 60 beams (the whole
neuraxis); the others had irradiation of the whole
brain and boost in posterior fossa with X6MV up
to 56Gy and spinaj cord with 18-24MeV
electrons. In the same time 11 children with
~edulloblastoma (8 boys, 3 girls) were
Irradiated. During this time we had 101 children
with all primary brain tumours aged between 2-
16 years (median 8.5 years). Two ot them were
older then 14 years.
Results: The longest survival (113 months)
had patient aged 18 years after nomadical
surgery, irradiation with Co-60 and
chemotherapy. 2 patients survived 58 months 3
patients 44 months, 1 patient 28 months. Amo~g
children 3 boys survived 79, 54 and 26 months
respectively. Other children died 2-24 months
after treatmenł.
ConcJusions: &middot; Medulloblastoma is
rare brain tumour. &middot; Radiotherapy
improved survivals fundamentally. &middot;
Analysis ot the survivals shows that follow-up
should be continued at least 10 years after
treatment. &middot; Young age is poor
prognostic factor - children died during first two
years after treatmenł.
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